1008 related articles for article (PubMed ID: 29445083)
1. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
2. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
5. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
Yan X; Chen J; Zhang C; Zhou S; Zhang Z; Chen J; Feng W; Li X; Tan Y
J Cell Mol Med; 2015 Jul; 19(7):1557-68. PubMed ID: 25823710
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.
Zhang C; Huang Z; Gu J; Yan X; Lu X; Zhou S; Wang S; Shao M; Zhang F; Cheng P; Feng W; Tan Y; Li X
Diabetologia; 2015 Aug; 58(8):1937-48. PubMed ID: 26040473
[TBL] [Abstract][Full Text] [Related]
8. Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects.
Li R; Liu Y; Shan YG; Gao L; Wang F; Qiu CG
Oxid Med Cell Longev; 2019; 2019():3206542. PubMed ID: 31354905
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK/Sirt1/PGC-1α signaling.
Jiang X; Chen J; Zhang C; Zhang Z; Tan Y; Feng W; Skibba M; Xin Y; Cai L
Endocrinology; 2015 Mar; 156(3):1156-70. PubMed ID: 25560828
[TBL] [Abstract][Full Text] [Related]
10. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
[TBL] [Abstract][Full Text] [Related]
12. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
[TBL] [Abstract][Full Text] [Related]
16. Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.
Zhang F; Lin X; Yu L; Li W; Qian D; Cheng P; He L; Yang H; Zhang C
J Cell Mol Med; 2016 Jul; 20(7):1352-66. PubMed ID: 26991817
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy.
Cheng Y; Zhang J; Guo W; Li F; Sun W; Chen J; Zhang C; Lu X; Tan Y; Feng W; Fu Y; Liu GC; Xu Z; Cai L
Free Radic Biol Med; 2016 Apr; 93():94-109. PubMed ID: 26849944
[TBL] [Abstract][Full Text] [Related]
18. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
Yang H; Mao Y; Tan B; Luo S; Zhu Y
Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
[TBL] [Abstract][Full Text] [Related]
19. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
